Philippe has a deep understanding of commercial and payer models across the political and economic spectrum. Before launching p-valorem (consulting) and Optichronix (digital therapeutic startup) during his tenure at Pfizer, Philippe held several market access and commercial senior roles during which he: Defined and supervised implementation of marketing & market access, regulatory and clinical development strategies for phase 2 & 3 assets. Launched 10+ medicines, vaccines, and OTC products. Secured reimbursement worldwide for internal medicines, immunology, oncology, hemophilia portfolio, and vaccines. For Women's Health products in the USA, redefined and supervised the execution of evidence generation strategy. Before living in New York, Philippe lived and worked in France and Germany.